bemvo.be

What It Is

BeMVO (Belgian Medicines Verification Organisation) is Belgium’s national medicines verification organization. It is responsible for supporting a safe and reliable pharmaceutical supply chain in Belgium and for operating/supporting the National Medicines Verification System (NMVS). Its goal is not a traditional firewall or endpoint security function, but rather to prevent falsified medicines from entering the legitimate supply chain under the EU FMD anti-falsified medicines directive, using unique packaging codes, 2D Matrix codes, and status verification.

Core Capabilities

In terms of protection type, BeMVO belongs to the pharmaceutical supply chain anti-counterfeiting and compliance verification system. Users such as pharmacies, hospital pharmacies, and wholesalers can verify medicine packs to confirm whether they are FMD-compliant and whether their status is active or inactive. In scenarios such as dispensing, export, destruction, or samples, packs can be decommissioned. The system generates alerts for anomalies such as “pack already INACTIVE,” indicating possible duplicate codes, incorrect decommissioning, or potential counterfeit risk. In deployment, end users typically connect through the FMD module in their own pharmacy or wholesaler software, using a login, password, TAN code, and certificate.

Pricing and Compliance

The main text does not disclose BeMVO’s pricing model or specific costs. In terms of compliance, it is explicitly based on EU Directive 2011/62/EU and Delegated Regulation 2016/161. Belgium began implementing the FMD on February 9, 2019, and entered full EU-FMD implementation for Belgium and Luxembourg on February 9, 2024.

Pros and Cons

Its strengths are its clear regulatory positioning, coverage of key participants in Belgium’s pharmaceutical supply chain, and extensive FAQ guidance on alerts, passwords, certificates, account lockouts, and handling anomalous packs. Its limitations are that it is not a general-purpose cybersecurity product, its scope is highly vertical, the actual user experience depends on third-party FMD software modules, and the public pages do not explain SLA, architecture, security certifications, or pricing.

Who It’s For and Access from China

It is suitable for pharmacies, hospital pharmacies, wholesalers, marketing authorization holders, and software providers operating within Belgium’s pharmaceutical distribution system. If a Chinese company is involved in compliant pharmaceutical distribution in Belgium or the EU, it can be regarded as one of the national verification systems it must integrate with. The main text does not provide information on access from China, so this remains unknown.